Open access chemical and clinical probes to support drug discovery

被引：79
作者：
Edwards, Aled M. [1 ]
Bountra, Chas [2 ]
Kerr, David J. [3 ]
Willson, Timothy M. [4 ]
机构：
[1] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada
[2] Univ Oxford, Struct Genom Consortium, Oxford, England
[3] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar
[4] GlaxoSmithKline, Discovery Med Chem, Res Triangle Pk, NC USA
来源：
NATURE CHEMICAL BIOLOGY | 2009年 / 5卷 / 07期
基金：
加拿大健康研究院; 英国惠康基金;
关键词：
ORPHAN NUCLEAR RECEPTORS; SUBSTANCE-P; SYNOVIAL-FLUID; PAIN; BRADYKININ; INHIBITORS; ARTHRITIS; GENOMICS;
D O I：
10.1038/nchembio0709-436
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.
引用
收藏
页码：436 / 440
页数：5
相关论文
共 26 条
  • [11] PAIN, TENDERNESS, WHEAL AND FLARE INDUCED BY SUBSTANCE-P, BRADYKININ AND 5-HYDROXYTRYPTAMINE IN HUMANS
    JENSEN, K
    TUXEN, C
    PEDERSENBJERGAARD, U
    JANSEN, I
    [J]. CEPHALALGIA, 1991, 11 (04) : 175 - 182
  • [12] Orphan nuclear receptors: Shifting endocrinology into reverse
    Kliewer, SA
    Lehmann, JM
    Willson, TM
    [J]. SCIENCE, 1999, 284 (5415) : 757 - 760
  • [13] Chemical genetics: Where genetics and pharmacology meet
    Knight, Zachary A.
    Shokat, Kevan M.
    [J]. CELL, 2007, 128 (03) : 425 - 430
  • [14] Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor
    Mantyh, PW
    Rogers, SD
    Honore, P
    Allen, BJ
    Ghilardi, JR
    Li, J
    Daughters, RS
    Lappi, DA
    Wiley, RG
    Simone, DA
    [J]. SCIENCE, 1997, 278 (5336) : 275 - 279
  • [15] MARSHALL KW, 1990, ARTHRITIS RHEUM-US, V33, P87
  • [16] MENKES CJ, 1993, J RHEUMATOL, V20, P714
  • [17] Cholesteryl Ester Transfer Protein (CETP) Inhibitors: Is There Life After Torcetrapib?
    Neeli, Hemanth
    Rader, Daniel J.
    [J]. CARDIOLOGY CLINICS, 2008, 26 (04) : 537 - +
  • [18] Small molecules and chemical tools at the interface
    Newman, Robert H.
    Zhang, Jin
    [J]. NATURE CHEMICAL BIOLOGY, 2008, 4 (07) : 382 - 386
  • [19] ALGESIA AND LOCAL RESPONSES INDUCED BY NEUROKININ-A AND SUBSTANCE-P IN HUMAN-SKIN AND TEMPORAL MUSCLE
    PEDERSENBJERGAARD, U
    NIELSEN, LB
    JENSEN, K
    EDVINSSON, L
    JANSEN, I
    OLESEN, J
    [J]. PEPTIDES, 1989, 10 (06) : 1147 - 1152
  • [20] Rupniak Nadia M. J., 1999, P135
123